Company Filing History:
Years Active: 2015
Title: Simone Dill: Innovator in Bi-specific Antibodies
Introduction
Simone Dill is a prominent inventor based in Kulmbach, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of bi-specific antibodies. Her innovative work has the potential to enhance therapeutic and diagnostic applications.
Latest Patents
Simone Dill holds a patent for "Bi-specific digoxigenin binding antibodies." This invention relates to bispecific antibodies and antibody fragments that target a specific protein and a hapten, with the hapten being PEG or biotin, most preferably digoxigenin. The patent outlines methods for producing these antibodies, their use as a delivery platform for therapeutic or diagnostic agents, and pharmaceutical compositions containing said antibodies.
Career Highlights
Throughout her career, Simone has worked with notable companies, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to refine her expertise in antibody development and biotechnology.
Collaborations
Simone has collaborated with esteemed colleagues such as Birgit Bramlage and Ulrich Brinkmann. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Simone Dill's work in bi-specific antibodies represents a significant advancement in biotechnology. Her contributions have the potential to impact therapeutic and diagnostic fields positively.